Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts

Roberta Sanguineti, F. Monacelli, A. Parodi, A. L. Furfaro, R. Borghi, D. Pacini, Maria Adelaide Pronzato, P. Odetti, L. Molfetta, N. Traverso

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Osteoporosis is a metabolic multifaceted disorder, characterized by insufficient bone strength. It has been recently shown that advanced glycation end products (AGEs) play a role in senile osteoporosis, through bone cell impairment and altered biomechanical properties. Pentosidine (PENT), a well-characterized AGE, is also considered a biomarker of bone fracture. Adequate responses to various hormones, such as 1,25-dihydroxyvitamin D3, are prerequisites for optimal osteoblasts functioning. Vitamin K2 is known to enhance in vitro and in vitro vitamin D-induced bone formation. The aim of the study was to assess the effects of Vitamins D3 and K2 and PENT on in vitro osteoblast activity, to convey a possible translational clinical message. Ex vivo human osteoblasts cultured, for 3 weeks, with vitamin D3 and vitamin K2were exposed to PENT, a well-known advanced glycoxidation end product for the last 72 hours. Experiments with PENT alone were also carried out. Gene expression of specific markers of bone osteoblast maturation [alkaline phosphatase, ALP; collagen I, COL lai; and osteocalcin (bone-Gla-protein) BGPJ was measured, together with the receptor activator of nuclear factor kappa-B ligand/osteoproteregin (RANKL/OPG) ratio to assess bone remodeling. Expression of RAGE, a well-characterized receptor of AGEs, was also assessed. PENT+vitamins slightly inhibited ALP secretion while not affecting gene expression, indicating hampered osteoblast functional activity. PENT+vitamins up-regulated collagen gene expression, while protein secretion was unchanged. Intracellular collagen levels were partially decreased, and a significant reduction in BGP gene expression and intracellular protein concentration were both reported after PENT exposure. The RANKL/OPG ratio was increased, favouring bone reabsorption. RAGE gene expression significantly decreased. These results were confirmed by a lower mineralization rate. We provided in vitro evidence that glycoxidation might interfere with the maturation of osteoblasts, leading to morphological modifications, cellular malfunctioning, and inhibition of the calcification process. However, these processes may be all partially counterbalanced by vitamins D3 and K2. Therefore, detrimental AGE accumulation in bone might be attenuated and/or reversed by the presence or supplementation of vitamins D3 and K2.

Original languageEnglish
Pages (from-to)713-726
Number of pages14
JournalJournal of Biological Regulators and Homeostatic Agents
Volume30
Issue number3
Publication statusPublished - 2016

Fingerprint

Vitamin K 2
Cholecalciferol
Osteoblasts
Gene Expression
Bone and Bones
Vitamins
RANK Ligand
Collagen
Osteocalcin
Osteoporosis
Advanced Glycosylation End Products
Calcitriol
Bone Remodeling
Bone Fractures
pentosidine
Osteogenesis
Vitamin D
Alkaline Phosphatase
Proteins
Biomarkers

Keywords

  • AGEs
  • Osteoblasts
  • Osteoporosis
  • Reabsorptive effects
  • Vit K2 and Vit D3 supplementation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sanguineti, R., Monacelli, F., Parodi, A., Furfaro, A. L., Borghi, R., Pacini, D., ... Traverso, N. (2016). Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts. Journal of Biological Regulators and Homeostatic Agents, 30(3), 713-726.

Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts. / Sanguineti, Roberta; Monacelli, F.; Parodi, A.; Furfaro, A. L.; Borghi, R.; Pacini, D.; Pronzato, Maria Adelaide; Odetti, P.; Molfetta, L.; Traverso, N.

In: Journal of Biological Regulators and Homeostatic Agents, Vol. 30, No. 3, 2016, p. 713-726.

Research output: Contribution to journalArticle

Sanguineti, R, Monacelli, F, Parodi, A, Furfaro, AL, Borghi, R, Pacini, D, Pronzato, MA, Odetti, P, Molfetta, L & Traverso, N 2016, 'Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts', Journal of Biological Regulators and Homeostatic Agents, vol. 30, no. 3, pp. 713-726.
Sanguineti, Roberta ; Monacelli, F. ; Parodi, A. ; Furfaro, A. L. ; Borghi, R. ; Pacini, D. ; Pronzato, Maria Adelaide ; Odetti, P. ; Molfetta, L. ; Traverso, N. / Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts. In: Journal of Biological Regulators and Homeostatic Agents. 2016 ; Vol. 30, No. 3. pp. 713-726.
@article{0a9492a71c5944c08e5fb28bc2f681f8,
title = "Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts",
abstract = "Osteoporosis is a metabolic multifaceted disorder, characterized by insufficient bone strength. It has been recently shown that advanced glycation end products (AGEs) play a role in senile osteoporosis, through bone cell impairment and altered biomechanical properties. Pentosidine (PENT), a well-characterized AGE, is also considered a biomarker of bone fracture. Adequate responses to various hormones, such as 1,25-dihydroxyvitamin D3, are prerequisites for optimal osteoblasts functioning. Vitamin K2 is known to enhance in vitro and in vitro vitamin D-induced bone formation. The aim of the study was to assess the effects of Vitamins D3 and K2 and PENT on in vitro osteoblast activity, to convey a possible translational clinical message. Ex vivo human osteoblasts cultured, for 3 weeks, with vitamin D3 and vitamin K2were exposed to PENT, a well-known advanced glycoxidation end product for the last 72 hours. Experiments with PENT alone were also carried out. Gene expression of specific markers of bone osteoblast maturation [alkaline phosphatase, ALP; collagen I, COL lai; and osteocalcin (bone-Gla-protein) BGPJ was measured, together with the receptor activator of nuclear factor kappa-B ligand/osteoproteregin (RANKL/OPG) ratio to assess bone remodeling. Expression of RAGE, a well-characterized receptor of AGEs, was also assessed. PENT+vitamins slightly inhibited ALP secretion while not affecting gene expression, indicating hampered osteoblast functional activity. PENT+vitamins up-regulated collagen gene expression, while protein secretion was unchanged. Intracellular collagen levels were partially decreased, and a significant reduction in BGP gene expression and intracellular protein concentration were both reported after PENT exposure. The RANKL/OPG ratio was increased, favouring bone reabsorption. RAGE gene expression significantly decreased. These results were confirmed by a lower mineralization rate. We provided in vitro evidence that glycoxidation might interfere with the maturation of osteoblasts, leading to morphological modifications, cellular malfunctioning, and inhibition of the calcification process. However, these processes may be all partially counterbalanced by vitamins D3 and K2. Therefore, detrimental AGE accumulation in bone might be attenuated and/or reversed by the presence or supplementation of vitamins D3 and K2.",
keywords = "AGEs, Osteoblasts, Osteoporosis, Reabsorptive effects, Vit K2 and Vit D3 supplementation",
author = "Roberta Sanguineti and F. Monacelli and A. Parodi and Furfaro, {A. L.} and R. Borghi and D. Pacini and Pronzato, {Maria Adelaide} and P. Odetti and L. Molfetta and N. Traverso",
year = "2016",
language = "English",
volume = "30",
pages = "713--726",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "3",

}

TY - JOUR

T1 - Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts

AU - Sanguineti, Roberta

AU - Monacelli, F.

AU - Parodi, A.

AU - Furfaro, A. L.

AU - Borghi, R.

AU - Pacini, D.

AU - Pronzato, Maria Adelaide

AU - Odetti, P.

AU - Molfetta, L.

AU - Traverso, N.

PY - 2016

Y1 - 2016

N2 - Osteoporosis is a metabolic multifaceted disorder, characterized by insufficient bone strength. It has been recently shown that advanced glycation end products (AGEs) play a role in senile osteoporosis, through bone cell impairment and altered biomechanical properties. Pentosidine (PENT), a well-characterized AGE, is also considered a biomarker of bone fracture. Adequate responses to various hormones, such as 1,25-dihydroxyvitamin D3, are prerequisites for optimal osteoblasts functioning. Vitamin K2 is known to enhance in vitro and in vitro vitamin D-induced bone formation. The aim of the study was to assess the effects of Vitamins D3 and K2 and PENT on in vitro osteoblast activity, to convey a possible translational clinical message. Ex vivo human osteoblasts cultured, for 3 weeks, with vitamin D3 and vitamin K2were exposed to PENT, a well-known advanced glycoxidation end product for the last 72 hours. Experiments with PENT alone were also carried out. Gene expression of specific markers of bone osteoblast maturation [alkaline phosphatase, ALP; collagen I, COL lai; and osteocalcin (bone-Gla-protein) BGPJ was measured, together with the receptor activator of nuclear factor kappa-B ligand/osteoproteregin (RANKL/OPG) ratio to assess bone remodeling. Expression of RAGE, a well-characterized receptor of AGEs, was also assessed. PENT+vitamins slightly inhibited ALP secretion while not affecting gene expression, indicating hampered osteoblast functional activity. PENT+vitamins up-regulated collagen gene expression, while protein secretion was unchanged. Intracellular collagen levels were partially decreased, and a significant reduction in BGP gene expression and intracellular protein concentration were both reported after PENT exposure. The RANKL/OPG ratio was increased, favouring bone reabsorption. RAGE gene expression significantly decreased. These results were confirmed by a lower mineralization rate. We provided in vitro evidence that glycoxidation might interfere with the maturation of osteoblasts, leading to morphological modifications, cellular malfunctioning, and inhibition of the calcification process. However, these processes may be all partially counterbalanced by vitamins D3 and K2. Therefore, detrimental AGE accumulation in bone might be attenuated and/or reversed by the presence or supplementation of vitamins D3 and K2.

AB - Osteoporosis is a metabolic multifaceted disorder, characterized by insufficient bone strength. It has been recently shown that advanced glycation end products (AGEs) play a role in senile osteoporosis, through bone cell impairment and altered biomechanical properties. Pentosidine (PENT), a well-characterized AGE, is also considered a biomarker of bone fracture. Adequate responses to various hormones, such as 1,25-dihydroxyvitamin D3, are prerequisites for optimal osteoblasts functioning. Vitamin K2 is known to enhance in vitro and in vitro vitamin D-induced bone formation. The aim of the study was to assess the effects of Vitamins D3 and K2 and PENT on in vitro osteoblast activity, to convey a possible translational clinical message. Ex vivo human osteoblasts cultured, for 3 weeks, with vitamin D3 and vitamin K2were exposed to PENT, a well-known advanced glycoxidation end product for the last 72 hours. Experiments with PENT alone were also carried out. Gene expression of specific markers of bone osteoblast maturation [alkaline phosphatase, ALP; collagen I, COL lai; and osteocalcin (bone-Gla-protein) BGPJ was measured, together with the receptor activator of nuclear factor kappa-B ligand/osteoproteregin (RANKL/OPG) ratio to assess bone remodeling. Expression of RAGE, a well-characterized receptor of AGEs, was also assessed. PENT+vitamins slightly inhibited ALP secretion while not affecting gene expression, indicating hampered osteoblast functional activity. PENT+vitamins up-regulated collagen gene expression, while protein secretion was unchanged. Intracellular collagen levels were partially decreased, and a significant reduction in BGP gene expression and intracellular protein concentration were both reported after PENT exposure. The RANKL/OPG ratio was increased, favouring bone reabsorption. RAGE gene expression significantly decreased. These results were confirmed by a lower mineralization rate. We provided in vitro evidence that glycoxidation might interfere with the maturation of osteoblasts, leading to morphological modifications, cellular malfunctioning, and inhibition of the calcification process. However, these processes may be all partially counterbalanced by vitamins D3 and K2. Therefore, detrimental AGE accumulation in bone might be attenuated and/or reversed by the presence or supplementation of vitamins D3 and K2.

KW - AGEs

KW - Osteoblasts

KW - Osteoporosis

KW - Reabsorptive effects

KW - Vit K2 and Vit D3 supplementation

UR - http://www.scopus.com/inward/record.url?scp=85012237838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012237838&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85012237838

VL - 30

SP - 713

EP - 726

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 3

ER -